Cargando…
Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer
PURPOSE: This study aimed to identify the prognostic value of early metabolic response assessed using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) during radiation therapy (RT) for cervical cancer. MATERIALS AND METHODS: We identified 116 patients treated wi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291185/ https://www.ncbi.nlm.nih.gov/pubmed/33321566 http://dx.doi.org/10.4143/crt.2020.1251 |
_version_ | 1783724599619354624 |
---|---|
author | Kim, Nalee Park, Won Cho, Won Kyung Bae, Duk-Soo Kim, Byoung-Gie Lee, Jeong-Won Kim, Tae-Joong Choi, Chel Hun Lee, Yoo-Young Cho, Young Seok |
author_facet | Kim, Nalee Park, Won Cho, Won Kyung Bae, Duk-Soo Kim, Byoung-Gie Lee, Jeong-Won Kim, Tae-Joong Choi, Chel Hun Lee, Yoo-Young Cho, Young Seok |
author_sort | Kim, Nalee |
collection | PubMed |
description | PURPOSE: This study aimed to identify the prognostic value of early metabolic response assessed using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) during radiation therapy (RT) for cervical cancer. MATERIALS AND METHODS: We identified 116 patients treated with definitive RT, including FDG-PET/CT–guided intracavitary brachytherapy, between 2009 and 2018. We calculated parameters including maximum (SUV(max)) and mean standardized uptake values (SUV(mean)), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) for baseline FDG-PET/CT (PET(base)) and image-guided brachytherapy planning FDG-PET/CT (PET(IGBT)). Multivariable analyses of disease-free survival (DFS) and overall survival (OS) were performed. RESULTS: We observed a time-dependent decrease in PET parameters between PET(base) and PET(IGBT); ΔSUV(max), ΔSUV(mean), ΔMTV, and ΔTLG were 65%, 61%, 78%, and 93%, respectively. With a median follow-up of 59.5 months, the 5-year DFS and OS rates were 66% and 79%, respectively. Multivariable analysis demonstrated that ΔSUV(max) ≥ 50% was associated with favorable DFS (hazard ratio [HR], 2.56; 95% confidence interval [CI], 1.14 to 5.77) and OS (HR, 5.14; 95% CI, 1.55 to 17.01). Patients with ΔSUV(max) ≥ 50% (n=87) showed better DFS and OS than those with ΔSUV(max) < 50% (n=29) (DFS, 76% vs. 35%, p < 0.001; OS, 90% vs. 41%, p < 0.001, respectively). Adenocarcinoma was frequently observed in ΔSUV(max) < 50% compared to ΔSUV(max) ≥ 50% (27.6% vs. 10.3%, p=0.003). In addition, models incorporating metabolic parameters showed improved accuracy for predicting DFS (p=0.012) and OS (p=0.004) than models with clinicopathologic factors. CONCLUSION: Changes in metabolic parameters, especially those in SUV(max) by > 50%, can help improve survival outcome predictions for patients with cervical cancer treated with definitive RT. |
format | Online Article Text |
id | pubmed-8291185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Korean Cancer Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-82911852021-08-04 Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer Kim, Nalee Park, Won Cho, Won Kyung Bae, Duk-Soo Kim, Byoung-Gie Lee, Jeong-Won Kim, Tae-Joong Choi, Chel Hun Lee, Yoo-Young Cho, Young Seok Cancer Res Treat Original Article PURPOSE: This study aimed to identify the prognostic value of early metabolic response assessed using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) during radiation therapy (RT) for cervical cancer. MATERIALS AND METHODS: We identified 116 patients treated with definitive RT, including FDG-PET/CT–guided intracavitary brachytherapy, between 2009 and 2018. We calculated parameters including maximum (SUV(max)) and mean standardized uptake values (SUV(mean)), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) for baseline FDG-PET/CT (PET(base)) and image-guided brachytherapy planning FDG-PET/CT (PET(IGBT)). Multivariable analyses of disease-free survival (DFS) and overall survival (OS) were performed. RESULTS: We observed a time-dependent decrease in PET parameters between PET(base) and PET(IGBT); ΔSUV(max), ΔSUV(mean), ΔMTV, and ΔTLG were 65%, 61%, 78%, and 93%, respectively. With a median follow-up of 59.5 months, the 5-year DFS and OS rates were 66% and 79%, respectively. Multivariable analysis demonstrated that ΔSUV(max) ≥ 50% was associated with favorable DFS (hazard ratio [HR], 2.56; 95% confidence interval [CI], 1.14 to 5.77) and OS (HR, 5.14; 95% CI, 1.55 to 17.01). Patients with ΔSUV(max) ≥ 50% (n=87) showed better DFS and OS than those with ΔSUV(max) < 50% (n=29) (DFS, 76% vs. 35%, p < 0.001; OS, 90% vs. 41%, p < 0.001, respectively). Adenocarcinoma was frequently observed in ΔSUV(max) < 50% compared to ΔSUV(max) ≥ 50% (27.6% vs. 10.3%, p=0.003). In addition, models incorporating metabolic parameters showed improved accuracy for predicting DFS (p=0.012) and OS (p=0.004) than models with clinicopathologic factors. CONCLUSION: Changes in metabolic parameters, especially those in SUV(max) by > 50%, can help improve survival outcome predictions for patients with cervical cancer treated with definitive RT. Korean Cancer Association 2021-07 2020-12-09 /pmc/articles/PMC8291185/ /pubmed/33321566 http://dx.doi.org/10.4143/crt.2020.1251 Text en Copyright © 2021 by the Korean Cancer Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kim, Nalee Park, Won Cho, Won Kyung Bae, Duk-Soo Kim, Byoung-Gie Lee, Jeong-Won Kim, Tae-Joong Choi, Chel Hun Lee, Yoo-Young Cho, Young Seok Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer |
title | Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer |
title_full | Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer |
title_fullStr | Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer |
title_full_unstemmed | Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer |
title_short | Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer |
title_sort | early metabolic response assessed using (18)f-fdg-pet/ct for image-guided intracavitary brachytherapy can better predict treatment outcomes in patients with cervical cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291185/ https://www.ncbi.nlm.nih.gov/pubmed/33321566 http://dx.doi.org/10.4143/crt.2020.1251 |
work_keys_str_mv | AT kimnalee earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer AT parkwon earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer AT chowonkyung earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer AT baeduksoo earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer AT kimbyounggie earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer AT leejeongwon earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer AT kimtaejoong earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer AT choichelhun earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer AT leeyooyoung earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer AT choyoungseok earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer |